This $35 Retinol Serum Currently Has a 26,000 Person–Plus Wait List

By ·
This $35 Retinol Serum Currently Has a 26,000 Person–Plus Wait List featured image

When Jackie Kim launched her “passion project” Moonlight Retinal Super Serum back in October, she anticipated it would be popular. Not only did the Maelove founder specifically create the product after receiving more than 25,000 customer requests for it, but she was especially proud of the fact that she was able to release a retinol that worked with the notoriously hard-to-deal-with ingredient of retinaldehyde in a way that kept the formula stable and potent, all while infusing it with hydrating ingredients. 

Kim was spot-on with her assumption, selling through an initial stock of more 7,600 bottles in less than six days—which breaks down to one bottle of Moonlight every minute for five days straight in the days after the launch. The new-year stats are even more impressive, as the brand shares there is currently a 26K wait list for the serum and, with a re-stock not on the horizon until March, they expect an even larger number to contend with within the next month.

“People took notice of this one,” Kim shares. “Too much retinol is counterproductive, and a lot of people are scared of it, but we kept sensitive skin in mind when we did this. The time-released, stabilized retinaldehyde at 0.11-percent concentration is what makes it different, as does the skin-soothing blend of blend of nourishers like niacinamide, bisabolol, ceramide, tea extracts, hyaluronic acid and squalene.”

While we can’t completely divulge what’s next for Kim’s portfolio, we can share that she has plans to roll out a full “retinol collection” for the brand, with two new launches slated to drop very soon in February.

Find a Doctor

Find a NewBeauty "Top Beauty Doctor" Near you

Give the Gift of Luxury

NewBeauty uses cookies for various reasons, including to analyze and improve its content and advertising. Please review our Privacy Policy and Terms of Use for more about how we use this data. By continuing to use this site, you agree to these policies.